Novavax Inc. Stock Rises Monday, Still Underperforms Market

RPC Inc

Change company Symbol lookup

Select an option...

RES RPC Inc

WOWI Metro One Telecommunications Inc

PDD Pinduoduo Inc

VIV Telefonica Brasil SA

EXPR Express Inc

KVSC Khosla Ventures Acquisition III Co

BWV Blue Water Vaccines Inc

ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund

LGO Largo Inc

ONTO Onto Innovation Inc

Energy : Energy Equipment & Services | Small Cap Growth

Company profile

RPC, Inc. is a holding company of Cudd Energy Services, Cudd Pressure Control, Thru Tubing Solutions and Patterson Services. The Company provides a range of oilfield services and equipment primarily to independent and oilfield companies, which is engaged in the exploration, production and development of oil and gas properties throughout the United States, including the Gulf of Mexico, mid-continent, southwest, Appalachian and Rocky Mountain regions, and in selected international markets. It has two segments. Technical Services segment includes its oil and gas services, which utilizes people and equipment to perform value-added completion, production and maintenance services directly to a customer well. Support Services segment includes all of the services, which provides equipment offered off the well site without it personnel and services, which are provided in support of customer operations off the well site such as classroom and computer training, and other consulting services.

Novavax Inc. Stock Rises Monday, Still Underperforms Market

5:14 pm ET November 7, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) inched 0.15% higher to $19.43 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.85% to 10,564.52 and the Dow Jones Industrial Average rising 1.31% to 32,827.00. The stock's rise snapped a five-day losing streak. Novavax Inc. closed $217.07 below its 52-week high ($236.50), which the company reached on December 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Replimune Group Inc. (REPL) fell 4.96% to $17.62, VBI Vaccines Inc. (VBIV) rose 2.25% to $0.65, and AnaptysBio Inc. (ANAB) fell 1.95% to $29.09. Trading volume (4.0 M) remained 1.0 million below its 50-day average volume of 5.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 7, 2022.

(END) Dow Jones Newswires

November 07, 2022 17:14 ET (22:14 GMT)